Wells Fargo Upgrades Five Prime Therapeutics (FPRX) to Overweight
Tweet
Share
E-mailGet Alerts FPRX Hot Sheet
Price: $38.00 --0%
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 8
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 8
Join SI Premium – FREE
Wells Fargo analyst Jim Birchenough upgraded Five Prime Therapeutics (NASDAQ: FPRX) from Equal Weight to Overweight with a price target of $34.00.
For an analyst ratings summary and ratings history on Five Prime Therapeutics click here. For more ratings news on Five Prime Therapeutics click here.
Shares of Five Prime Therapeutics closed at $5.34 yesterday.
You May Also Be Interested In
- Wells Fargo Upgrades FOX Corp. (FOXA) to Overweight
- Ladenburg Thalmann Upgrades ONE Gas Inc. (OGS) to Buy
- Citi upgrades Establishment Labs to Buy with $92 target
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
